Patents by Inventor Adrienne L. Gilbert

Adrienne L. Gilbert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of tiagabine for treatment of diabetic neuropathy and migraine
    Patent number: 6872734
    Abstract: (R)-N-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid and salts thereof are effective GABA uptake inhibitory compounds and exert pharmacological effects on pain associated with diabetic neuropathy and migraine.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: March 29, 2005
    Assignee: Abbott Laboratories
    Inventors: Stephen D. Collins, Roger L. Deaton, William J. Giardina, Adrienne L. Gilbert
  • Use of tiagabine for treatment of diabetic neuropathy and migraine
    Publication number: 20020103236
    Abstract: (R)-N-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid and salts thereof are effective GABA uptake inhibitory compounds and exert pharmacological effects on pain associated with diabetic neuropathy and migraine.
    Type: Application
    Filed: October 18, 2001
    Publication date: August 1, 2002
    Inventors: Stephen D. Collins, Roger L. Deaton, William J. Giardina, Adrienne L. Gilbert
  • Use of superoxide dismutase in specimen diluent
    Patent number: 5330893
    Abstract: An improved method for detecting antibodies is disclosed. The method involves the steps of a) mixing the specimen with a diluent comprising superoxide dismutase, and b) contacting the diluted specimen with at least one recombinant antigen expressed as a fusion protein with superoxide dismutase.
    Type: Grant
    Filed: May 10, 1993
    Date of Patent: July 19, 1994
    Assignee: Abbott Laboratories
    Inventors: Adrienne L. Gilbert, James L. Stewart, Sarah L. Kidd, George J. Dawson